hPTH 1–34 treatment of osteoporosis with added hormone replacement therapy: Biochemical, kinetic and histological responses
- 1 June 1991
- journal article
- Published by Springer Nature in Osteoporosis International
- Vol. 1 (3) , 162-170
- https://doi.org/10.1007/bf01625448
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.BMJ, 1990
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- The assessment of bone formation and bone resorption in osteoporosis: A comparison between tetracycline-based iliac histomorphometry and whole body 85Sr kineticsJournal of Bone and Mineral Research, 1987
- Periodic courses of human 1–34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosisEuropean Journal of Clinical Investigation, 1987
- Estimation of whole body bone resorption rate: A comparison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry.BMJ, 1984
- Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of actionMetabolism, 1983
- Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.BMJ, 1980
- SENSITIVE ASSAY FOR BIOLOGICALLY ACTIVE FRAGMENT OF HUMAN PARATHYROID HORMONEThe Lancet, 1977
- Bone Turnover Model based on a Continuously Expanding Exchangeable Calcium PoolNature, 1969